Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples